A retrospective study analysing association between ß-cell function and glycemic response to Dulaglutide in patients with Type 2 Diabetes
Latest Information Update: 17 Mar 2022
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 13 Mar 2022 Results published in the Diabetes Therapy
- 09 Aug 2021 New trial record
- 29 Jun 2021 Results presented at the 81st Annual Scientific Sessions of the American Diabetes Association